1. "Deep-Dive analysis of the latest Lithium-Ion battery safety testing standards and regulations in Germany and China". (March 2023) Authors: Lin, C.; Burggräf, P.; Liu, L.; Adlon, T.; Mueller, K.; Beyer, M.; Xu, T.; Kammerer, V.; Hu, J.; Liu, S.; Wang, F. Journal: Renewable & sustainable energy reviews Issue: Volume 173(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 140P Patient-reported outcomes (PRO) following sintilimab plus platinum and gemcitabine as first-line treatment for advanced or metastatic squamous NSCLC: A randomized, double-blind, phase III study (Orient-12). (December 2022) Authors: Zhou, C.; Gao, G.; Fan, Y.; Liu, L.; Zhang, L.; Cang, S.; Zhou, J.; Li, B.; Yang, Y.; Li, J. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1T/2H mixed phase MoS2 in-situ grown on the surface of montmorillonite for selectively removing Pb2+. (June 2022) Authors: Cheng, Y.; Yang, S.; E, Tao; Liu, L.; Wang, D.; Qian, J. Journal: Materials today chemistry Issue: Volume 24(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 299 IDENTIFICATION OF MICRORNA-REGULATED PATHWAYS THROUGH AN INTEGRATION OF MICRORNA-MRNA MICROARRAY AND BIOINFORMATICS ANALYSIS IN CD34+ CELLS OF MYELODYSPLASTIC SYNDROMES. Issue 1 (April 2015) Authors: Xu, F.; Shi, W.; Liu, L.; He, Q.; Chang, C.; Li, X. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S148 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 3D-PTV flow measurements of Newtonian and non-Newtonian fluid blending in a batch reactor in the transitional regime. (31st December 2021) Authors: Romano, M.G.; Alberini, F.; Liu, L.; Simmons, M.J.H.; Stitt, E.H. Journal: Chemical engineering science Issue: Volume 246(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 4.6-GHz LHCD Launcher System of Experimental Advanced Superconducting Tokamak. (2nd January 2019) Authors: Liu, L.; Liu, F. K.; Jia, H.; Zhu, W. H.; Zhao, L. M.; Wang, X. J.; Shan, J. F.; Ding, B. J.; Li, M. H.; Yang, Y.; Feng, J. Q.; Wu, Z. G.; Li, Y.; Cheng, M.; Xu, L.; Wang, J.; Zhou, T. A.; Li, J. G. Journal: Fusion science and technology Issue: Volume 75:Number 1(2019) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 54 ADOPTIVELY TRANSFERRED HAPLOIDENTICAL NK CELLS AGAINST REFRACTORY MDS, HIGH-RISK MDS AND REFRACTORY AML AS A BRIDGE TO TRANSPLANTATION. COMPLETE REMISSION ASSOCIATED WITH DETECTABLE NK CELLS. (April 2015) Authors: Bjorklund, A.T.; Carlsten, M.; Liu, L.; Schaffer, M.; Watz, E.; Palma, M.; Hansson, L.; Mollgard, L.; Cooley, S.A.; Miller, J.S.; Ljungman, P.T.; Hellstrom-Lindberg, E.; Ljunggren, H.G.; Malmberg, K.J. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 71P Real-world treatment patterns and clinical outcomes for patients who received sintilimab (Sint) in first-line treatment of advanced non-small cell lung cancer (NSCLC) in China: A multicenter retrospective observational study. (December 2022) Authors: Yu, Y.; Shang, L.; Xie, Q.; Ying, K.; Jin, B.; Zhang, L.; Liu, L.; Li, J.; Ding, W. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 74P The safety, tolerability, and preliminary antitumor activity of sitravatinib plus tislelizumab in patients (pts) with locally recurrent or metastatic triple-negative breast cancer (TNBC): A multi-cohort, phase II trial. (December 2022) Authors: Liu, L.; Fan, L.; Jin, X.; Xu, Y.; Wu, S.; Yang, Y.; Chen, L.; Zhang, W.; Ma, L.; Hu, X.; Wang, Z.; Jiang, Y.; Shao, Z. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 9C.01: WHICH RISK FACTORS ARE IMPORTANT FOR ENDPOINT CARDIOVASCULAR EVENTS IN THE FEVER STUDY? A PRACTICAL APPLICATION OF ROC CURVES IN CLINICAL TRIALS. (June 2015) Authors: Zhang, X.; Zhang, Y.; Liu, L.; Zanchetti, A. Journal: Journal of hypertension Issue: Volume 33(2015)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗